Clinical Trial Update: Combination Chemotherapy, Radiation Therapy, and Surgery in Treating Patients With Primary or Recurrent Sarcoma [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating combination chemotherapy, radiation therapy, and surgery for primary or recurrent soft tissue sarcoma has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Soft Tissue Sarcoma

Snippet

Sponsor: Radiation Therapy Oncology Group | Conditions: Stage III Adult Soft Tissue Sarcoma, Recurrent Adult Soft Tissue Sarcoma | Phase 2 | Status: WITHDRAWN